ACET Q1 2022 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$76M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$25M+727.7% YoY

Gross Profit

$25M100.0% margin

Operating Income

$5M18.8% margin

Net Income

$5M18.5% margin

EPS (Diluted)

$1.60

QoQ Revenue Growth

+357.0%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$1M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$340M

Total Liabilities

$29M

Stockholders' Equity

$311M

Cash & Equivalents

$278M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	-$4M	+727.7%
Gross Profit	$25M	-$4M	+727.7%
Operating Income	$5M	-$21M	+122.0%
Net Income	$5M	-$21M	+121.7%